Bäz, L.; Roßberg, M.; Grün, K.; Kretzschmar, D.; Berndt, A.; Schulze, P.C.; Jung, C.; Franz, M.
Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A+ Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling. J. Clin. Med. 2021, 10, 2559.
https://doi.org/10.3390/jcm10122559
AMA Style
Bäz L, Roßberg M, Grün K, Kretzschmar D, Berndt A, Schulze PC, Jung C, Franz M.
Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A+ Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling. Journal of Clinical Medicine. 2021; 10(12):2559.
https://doi.org/10.3390/jcm10122559
Chicago/Turabian Style
Bäz, Laura, Michelle Roßberg, Katja Grün, Daniel Kretzschmar, Alexander Berndt, P. Christian Schulze, Christian Jung, and Marcus Franz.
2021. "Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A+ Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling" Journal of Clinical Medicine 10, no. 12: 2559.
https://doi.org/10.3390/jcm10122559
APA Style
Bäz, L., Roßberg, M., Grün, K., Kretzschmar, D., Berndt, A., Schulze, P. C., Jung, C., & Franz, M.
(2021). Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A+ Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling. Journal of Clinical Medicine, 10(12), 2559.
https://doi.org/10.3390/jcm10122559
